Healthcare Professionals
MRI SureScan Pacing Leads
for Bradyarrhythmia Management
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Healthcare Professionals
for Bradyarrhythmia Management
Worldwide, it is estimated that up to 75% of patients with implanted cardiac devices are expected to need an MRI scan during the lifetime of their devices.1 Five SureScan™ pacing lead options allow patients to undergo an MRI under specific conditions for use when used in combination with a SureScan cardiac device.
Model 3830 is a MR Conditional-licensed pacing lead for conduction system pacing, to help treat bradycardia patients who have a pacemaker
The 3830 lead is licenced for providing conduction system pacing in Canada, including both His-bundle pacing (HBP) and left bundle branch area pacing (LBBAP).
The 4076 and 5076 pacing leads are MR Conditional and safe for use in the MRI environment.
The electrically active helix of the SureScan Model 5076 and 4076 leads are designed to extend easily for active fixation and retract for venous passage.
The CapSureFix Novus MRI SureScan Model 5076 was the second pacing lead to be approved for use in the MRI environment. More than 3.2 million of these leads have been sold worldwide with 97.6% reliability at 10 years.2,3
The 4074 and 4574 pacing leads are MR Conditional and safe for use in the MRI environment.
The CapSure Sense MRI SureScan, steroid-eluding leads with a ring-shaped tip and titanium nitride (TiN) microstructure are designed for optimal sensing and system performance resulting in better detection of ventricular Capture Management™.
Kalin R, et al. Pacing Clin Electrophysiol. 2005;28:326-328.
Vogl H. Total Sales of Sprint Quattro ICD Leads and 5076 pacing leads.Medtronic data on file. November 18, 2014.
DeBus B. Model 5076 Lead Survival Function Calculation. Medtronic data on file. August 2014.